Cargando…
Antiviral agents in the critically ill child
The treatment for most viral infections in children primarily is supportive. Severe viral illnesses and significant secondary complications that require treatment in the intensive care unit may occur in immunocompromised patients and also in infants and children who were previously healthy. Antivira...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
W.B. Saunders Company.
2000
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7173155/ https://www.ncbi.nlm.nih.gov/pubmed/32336897 http://dx.doi.org/10.1053/spid.0110035 |
_version_ | 1783524396820856832 |
---|---|
author | Munoz, Flor M. |
author_facet | Munoz, Flor M. |
author_sort | Munoz, Flor M. |
collection | PubMed |
description | The treatment for most viral infections in children primarily is supportive. Severe viral illnesses and significant secondary complications that require treatment in the intensive care unit may occur in immunocompromised patients and also in infants and children who were previously healthy. Antiviral agents with specific activity against certain respiratory viruses, herpesviruses, and enteric viruses are available. New drugs are under development, and their use in pediatric patients is a subject of active research. The clinician's knowledge of the mechanisms of action, spectrum of activity, and side effects of these drugs is an important tool for their judicious use in the treatment of the critically ill child. Copyright © 2000 by W.B. Saunders Company |
format | Online Article Text |
id | pubmed-7173155 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2000 |
publisher | W.B. Saunders Company. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71731552020-04-22 Antiviral agents in the critically ill child Munoz, Flor M. Semin Pediatr Infect Dis Article The treatment for most viral infections in children primarily is supportive. Severe viral illnesses and significant secondary complications that require treatment in the intensive care unit may occur in immunocompromised patients and also in infants and children who were previously healthy. Antiviral agents with specific activity against certain respiratory viruses, herpesviruses, and enteric viruses are available. New drugs are under development, and their use in pediatric patients is a subject of active research. The clinician's knowledge of the mechanisms of action, spectrum of activity, and side effects of these drugs is an important tool for their judicious use in the treatment of the critically ill child. Copyright © 2000 by W.B. Saunders Company W.B. Saunders Company. 2000-01 2005-11-02 /pmc/articles/PMC7173155/ /pubmed/32336897 http://dx.doi.org/10.1053/spid.0110035 Text en Copyright © 2000 W.B. Saunders Company. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Munoz, Flor M. Antiviral agents in the critically ill child |
title | Antiviral agents in the critically ill child |
title_full | Antiviral agents in the critically ill child |
title_fullStr | Antiviral agents in the critically ill child |
title_full_unstemmed | Antiviral agents in the critically ill child |
title_short | Antiviral agents in the critically ill child |
title_sort | antiviral agents in the critically ill child |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7173155/ https://www.ncbi.nlm.nih.gov/pubmed/32336897 http://dx.doi.org/10.1053/spid.0110035 |
work_keys_str_mv | AT munozflorm antiviralagentsinthecriticallyillchild |